Dow Jones stock MerckMRK and eight other bellwether pharmaceutical companies struck drug-pricing agreements with the Trump ...

TrumpRx: Discover how Trump's new agreements with major pharmaceutical companies aim to lower prescription drug costs for ...

On Friday, alongside leaders from Bristol Myers Squibb, Gilead Sciences, and Merck, among other leading pharma giants, the ...

Nine more drugmakers cut deals with the Trump administration. Not a subscriber? Sign up here to get this newsletter in your inbox. In today’s issue: The latest round of drug pricing deals. … How the ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

Trump unveiled drug pricing deals with leading pharmaceutical companies that promise “massive savings” for Medicaid patients and lower cash-pay prices, while offering firms tariff exemptions and ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump ...

President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than ...

Officials pledge ‘massive savings’ as companies agree to offer drugs at prices equal to those in other wealthy nations ...

The deals will slash the prices of medicines for the government's Medicaid program and for cash payers in Trump's latest bid ...

MRK faces looming Keytruda LOE, falling Gardasil sales and pricing pressure, but new products, pipeline and planned cost savings aim to offset the headwinds.